---
title: "MicuRx: Shareholder MicuRx Hong Kong plans to reduce its holdings by no more than 3% of the company's shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253029621.md"
description: "MicuRx announced that the company recently received a \"Notice of Shareholder Reduction Plan\" issued by MicuRx Hong Kong. Shareholder MicuRx Hong Kong plans to reduce its holdings of the company's shares by no more than 19,668,163 shares, which is no more than 3% of the company's total share capital, based on market conditions through centralized bidding and block trading"
datetime: "2025-08-14T11:33:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253029621.md)
  - [en](https://longbridge.com/en/news/253029621.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253029621.md)
generator: "portal-rs"
---

# MicuRx: Shareholder MicuRx Hong Kong plans to reduce its holdings by no more than 3% of the company's shares

MicuRx announced that the company recently received a "Notice of Shareholder Reduction Plan" issued by MicuRx Hong Kong. Shareholder MicuRx Hong Kong plans to reduce its holdings of the company's shares by no more than 19,668,163 shares, which is no more than 3% of the company's total share capital, depending on market conditions through centralized bidding and block trading

### Related Stocks

- [688373.CN](https://longbridge.com/en/quote/688373.CN.md)

## Related News & Research

- [Merz wins respite in German municipal polls but tougher tests to come](https://longbridge.com/en/news/298898492.md)
- [10 Years of Growth and Innovation at Almac Pharma Services’ Charnwood](https://longbridge.com/en/news/299034116.md)
- [Nanoscope Therapeutics to Present Long-Term MCO-010 Data at the 59th Annual Retina Society Meeting](https://longbridge.com/en/news/299039207.md)
- [Lundbeck announces last patient randomized in DEEp SEA, a Phase III trial of bexicaserin in Dravet syndrome](https://longbridge.com/en/news/299012192.md)
- [Dogwood Therapeutics completes enrollment in Halneuron Phase 2b chemotherapy-induced neuropathic pain trial](https://longbridge.com/en/news/298920470.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**